These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. Diehl SA; Schmidlin H; Nagasawa M; van Haren SD; Kwakkenbos MJ; Yasuda E; Beaumont T; Scheeren FA; Spits H J Immunol; 2008 Apr; 180(7):4805-15. PubMed ID: 18354204 [TBL] [Abstract][Full Text] [Related]
9. CD40 signaling drives B lymphocytes into an intermediate memory-like state, poised between naïve and plasma cells. Upadhyay M; Priya GK; Ramesh P; Madhavi MB; Rath S; Bal V; George A; Vaidya T J Cell Physiol; 2014 Oct; 229(10):1387-96. PubMed ID: 24482285 [TBL] [Abstract][Full Text] [Related]
11. Repression of the B cell identity factor Pax5 is not required for plasma cell development. Liu GJ; Jaritz M; Wöhner M; Agerer B; Bergthaler A; Malin SG; Busslinger M J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32780801 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849 [TBL] [Abstract][Full Text] [Related]
13. B-cell receptor signal strength influences terminal differentiation. Lechouane F; Bonaud A; Delpy L; Casola S; Oruc Z; Chemin G; Cogné M; Sirac C Eur J Immunol; 2013 Mar; 43(3):619-28. PubMed ID: 23280426 [TBL] [Abstract][Full Text] [Related]
15. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924 [TBL] [Abstract][Full Text] [Related]
16. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells. Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397 [TBL] [Abstract][Full Text] [Related]
17. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients. Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912 [TBL] [Abstract][Full Text] [Related]
18. Initiation of antigen receptor-dependent differentiation into plasma cells by calmodulin inhibition of E2A. Hauser J; Verma-Gaur J; Wallenius A; Grundström T J Immunol; 2009 Jul; 183(2):1179-87. PubMed ID: 19553523 [TBL] [Abstract][Full Text] [Related]
19. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861 [TBL] [Abstract][Full Text] [Related]
20. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]